Mitochondrial proteolytic stress induced by loss of mortalin function is rescued by Parkin and PINK1..pdf (7.05 MB)
0/0

Mitochondrial proteolytic stress induced by loss of mortalin function is rescued by Parkin and PINK1

Download (7.05 MB)
journal contribution
posted on 02.02.2016 by L. F. Burbulla, J. C. Fitzgerald, K. Stegen, J. Westermeier, A. K. Thost, H. Kato, D. Mokranjac, J. Sauerwald, L. Miguel Martins, D. Woitalla, D. Rapaport, O. Riess, T. Proikas-Cezanne, T. M. Rasse, R. Krüger
The mitochondrial chaperone mortalin was implicated in Parkinson's disease (PD) because of its reduced levels in the brains of PD patients and disease-associated rare genetic variants that failed to rescue impaired mitochondrial integrity in cellular knockdown models. To uncover the molecular mechanisms underlying mortalin-related neurodegeneration, we dissected the cellular surveillance mechanisms related to mitochondrial quality control, defined the effects of reduced mortalin function at the molecular and cellular levels and investigated the functional interaction of mortalin with Parkin and PINK1, two PD-related proteins involved in mitochondrial homeostasis. We found that reduced mortalin function leads to: (1) activation of the mitochondrial unfolded protein response (UPR(mt)), (2) increased susceptibility towards intramitochondrial proteolytic stress, (3) increased autophagic degradation of fragmented mitochondria and (4) reduced mitochondrial mass in human cells in vitro and ex vivo. These alterations caused increased vulnerability toward apoptotic cell death. Proteotoxic perturbations induced by either partial loss of mortalin or chemical induction were rescued by complementation with native mortalin, but not disease-associated mortalin variants, and were independent of the integrity of autophagic pathways. However, Parkin and PINK1 rescued loss of mortalin phenotypes via increased lysosomal-mediated mitochondrial clearance and required intact autophagic machinery. Our results on loss of mortalin function reveal a direct link between impaired mitochondrial proteostasis, UPR(mt) and PD and show that effective removal of dysfunctional mitochondria via either genetic (PINK1 and Parkin overexpression) or pharmacological intervention (rapamycin) may compensate mitochondrial phenotypes.

History

Citation

Cell Death Disease, 2014, 5, e1180

Author affiliation

/Organisation/COLLEGE OF MEDICINE, BIOLOGICAL SCIENCES AND PSYCHOLOGY/MBSP Non-Medical Departments/Molecular & Cell Biology

Version

VoR (Version of Record)

Published in

Cell Death Disease

Publisher

Nature Publishing Group

eissn

2041-4889

Acceptance date

14/02/2014

Copyright date

2014

Available date

02/02/2016

Publisher version

http://www.nature.com/cddis/journal/v5/n4/full/cddis2014103a.html

Language

en

Exports